Business Context and Reporting Period
This Form 10-K is for Reinvent Technology Partners Z, not operating Hippo Holdings Inc. It covers the period from inception on October 2, 2020 through December 31, 2020. The registrant was a Cayman Islands blank-check company formed to complete an initial business combination and had no operating history or operating revenue.
The company completed its initial public offering on November 23, 2020, selling 23.0 million units at $10.00 per unit and raising gross proceeds of $230.0 million. It also sold 4.4 million private placement warrants to its sponsor for $6.6 million.
Financial Metrics and Liquidity
| Metric | Period-end or period amount |
|---|---|
| Revenue | No operating revenue |
| General and administrative expense | $250,366 |
| Interest and unrealized gain on Trust Account investments | $18,693 |
| Net loss | $231,673 |
| Basic and diluted loss per Class B share | $0.04 loss per share |
| Cash in operating accounts | $622,985 |
| Prepaid expenses | $1.075 million |
| Cash and investments in Trust Account | $230.019 million |
| Total assets | $231.716 million |
| Total liabilities | $8.401 million |
| Shareholders’ equity | $5.000 million |
| Class A shares subject to possible redemption | 21,831,512 shares recorded at $218.315 million |
| Net cash used in operating activities | $1.234 million |
| Net cash used in investing activities | $230.000 million |
| Net cash provided by financing activities | $231.857 million |
| Debt | No long-term debt; approximately $60,000 of sponsor financing was repaid |
The filing does not provide meaningful operating margins because the company had no operating revenue. Substantially all Trust Account proceeds were invested in short-term U.S. Treasury securities or qualifying money-market funds. The company reported approximately $1.5 million of working capital and no outstanding working-capital loans at December 31, 2020.
Material Changes and Subsequent Developments
- Because the company was formed during 2020, there is no prior comparable operating period for meaningful year-over-year analysis.
- On March 3, 2021, the company announced a proposed merger with Hippo Enterprises Inc. under which the combined company would be renamed Hippo Holdings Inc. The proposed transaction contemplated Hippo equity valued at approximately $5.522 billion, consisting of a $5.0 billion enterprise value plus $522 million of Hippo cash as of December 31, 2020.
- Concurrent with the proposed merger agreement, investors subscribed for 55 million shares in a private investment in public equity transaction totaling $550 million.
- The proposed transaction was not reflected in the December 31, 2020 financial statements. The filing states that completion remained subject to specified conditions, including shareholder approval and other closing requirements.
- The company’s Class A shares began trading separately from its units on the NYSE on January 11, 2021.
Outlook, Risks, Contingencies, and Unusual Items
- The company expected to incur expenses for public-company compliance, target identification, due diligence, and transaction execution. Management believed available working capital and potential sponsor or affiliate financing would support operations through the earlier of a business combination or one year from the filing.
- The company was required to complete a business combination within the applicable combination period, generally 24 months after the IPO, or 27 months if it had executed specified transaction documentation within the first 24 months. If no transaction occurred, public shares would be redeemed from the Trust Account and warrants could expire worthless.
- Public shareholders had redemption rights, subject to the company’s net tangible asset requirements and other limitations. The sponsor and initial shareholders waived redemption rights on founder shares and agreed to vote founder shares in favor of a proposed business combination.
- The Trust Account was subject to potential claims by third parties. Although the sponsor agreed to indemnify the company in specified circumstances, the filing states that the sponsor might not have sufficient funds to satisfy those obligations.
- COVID-19 could adversely affect the company’s ability to identify, finance, negotiate, and complete a business combination. The filing states that the specific financial impact was not readily determinable.
- Management and directors had fiduciary or contractual obligations to other special purpose acquisition companies, Reinvent Capital, and other affiliated entities. These relationships created potential conflicts in allocating business opportunities and management time.
- The company paid or accrued related-party support and administrative costs under a $625,000 annual Support Services Agreement with Reinvent Capital. It paid $156,250 during the period, recognized approximately $52,000 of expense, and incurred approximately $12,000 of reimbursable expenses.
- The filing contains an internal inconsistency regarding the date of the Hippo merger agreement: the business discussion identifies March 3, 2021, while a subsequent-event note refers to February 23, 2021. The principal transaction disclosures identify March 3, 2021 as the execution date.
Most Important Facts to Verify
- Verify that this filing is for Reinvent Technology Partners Z, the SPAC predecessor, rather than an operating-company 10-K for Hippo Holdings Inc.
- Confirm the final status, closing date, consideration, shareholder approvals, redemption activity, PIPE funding, and financing terms of the proposed Hippo business combination.
- Reconcile the proposed transaction valuation, Hippo’s reported $522 million cash balance, and the number of shares ultimately issued.
- Review the Trust Account balance, deferred underwriting commissions of approximately $8.05 million, redemption obligations, and any third-party claims or sponsor indemnification capacity.
- Assess dilution from the 5.75 million founder shares, 5.75 million public warrants, 4.4 million private placement warrants, PIPE shares, and any additional financing or working-capital warrants.
- Review conflicts of interest involving the sponsor, Reinvent Capital, and other Reinvent SPACs, including how acquisition opportunities were allocated.
- Confirm the applicable combination deadline, any extensions, and the consequences for public shareholders and warrant holders if the transaction failed to close.